William L. Macias
2022
In 2022, William L. Macias earned a total compensation of $6.8M as Chief Medical Officer at Immunovant.
Compensation breakdown
| Bonus | $94,630 |
|---|---|
| Option Awards | $1,142,334 |
| Salary | $98,686 |
| Stock Awards | $961,887 |
| Other | $4,525,852 |
| Total | $6,823,389 |
Macias received $4.5M in other compensation, accounting for 66% of the total pay in 2022.
Macias also received $94.6K in bonus, $1.1M in option awards, $98.7K in salary and $961.9K in stock awards.
Rankings
In 2022, William L. Macias' compensation ranked 430th out of 5,756 executives tracked by ExecPay. In other words, Macias earned more than 92.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 430 out of 5,756 | 93rd |
Division Manufacturing | 178 out of 3,133 | 94th |
Major group Chemicals And Allied Products | 45 out of 1,419 | 97th |
Industry group Drugs | 34 out of 1,320 | 97th |
Industry Biological Products, Except Diagnostic Substances | 10 out of 291 | 97th |
Source: SEC filing on June 30, 2022.
Macias' colleagues
We found two more compensation records of executives who worked with William L. Macias at Immunovant in 2022.